New Evidence for Spinal Membrane as a Source of Stem Cells May Advance Treatment of Spinal Cord Injuries
News
Italian and Spanish scientists studying the use of stem cells for treating spinal cord injuries have provided the first evidence to show that meninges, the membrane which envelops the central nervous system, is a potential source of self-renewing stem cells. The research, published in Stem Cells, develops the understanding of cell activation in central nervous system injuries; advancing research into new treatments for spinal injuries and degenerative brain disorders.
|
|
Spinal cord injury
News
The use of mesenchymal stem cells for a variety have diseases has been published. This includes conditions such as heart failure,liver failure, stroke, and lupus. One of the attractive features of mesenchymal stem cells is that they can differentiate into numerous tissues while at the same time exerting anti-inflammatory activities.
|
|
Stem Cell institute cellmedicine successfully treats spinal cord injury patient with adult stem cells
News
The Stem Cell Institute reported today recovery of a spinal cord injury patient that was treated with a unique combination stem cell treatment. The patient suffered a crush fracture of the L1 vertebral body on May 13th, 2008 after a single propeller engine airplane crash. As a result of the crash, the patient had severe neuropathic pain, loss of sexual and bladder function, as well as loss of sensation in the legs.
|
|
StemCells, Inc. Initiates World¡¯s First Neural Stem Cell Trial In Spinal Cord Injury
News
StemCells Inc announced today they are initiating a clinical trial using their fetal derived neural progenitor cells for the treatment of spinal cord injuries. Previously the company had reported that their stem cells, called HuCNS-SC, are capable of differentiating into various neural lineage cells including neurons, oligodendrocytes, and astrocytes. The fact that HuCNS-SC are derived from fetal sources allows them to possess a lower ability to stimulate immune responses, therefore, the cells can be used as an ¡°off the shelf¡± product.
|
|
|
|
|
